+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Hidradenitis Suppurativa Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767311
  • Report
  • April 2019
  • Region: Global
  • 71 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Bayer AG
  • Celgene Corp
  • MORE
The global clinical trial report- “2019 Hidradenitis Suppurativa Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hidradenitis Suppurativa. It presents in-depth analysis of Hidradenitis Suppurativa clinical trials across markets and companies. The research work is for providing complete understanding into trends in Hidradenitis Suppurativa.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Hidradenitis Suppurativa clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Hidradenitis Suppurativa

The research work is prepared through extensive and continuous research on Hidradenitis Suppurativa trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Hidradenitis Suppurativa patients are identified
  • The report includes panorama of Hidradenitis Suppurativa clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Hidradenitis Suppurativa clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Bayer AG
  • Celgene Corp
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Hidradenitis Suppurativa Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Hidradenitis Suppurativa Clinical Trials by Region
2.2.2 Average Enrollment of Hidradenitis Suppurativa Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Hidradenitis Suppurativa Treatment, 2019

3. Region wise Hidradenitis Suppurativa Clinical Trials
3.1 Asia Pacific Hidradenitis Suppurativa Clinical Trials by Country
3.2 Europe Hidradenitis Suppurativa Clinical Trials by Country
3.3 North America Hidradenitis Suppurativa Clinical Trials by Country
3.4 Middle East and Africa Hidradenitis Suppurativa Clinical Trials by Country
3.5 South and Central America Hidradenitis Suppurativa Clinical Trials by Country

4. Hidradenitis Suppurativa Clinical Trial Trends
4.1 Start Year wise Hidradenitis Suppurativa Clinical Trials
4.2 Phase wise Hidradenitis Suppurativa Clinical Trials
4.3 Trial Status wise Hidradenitis Suppurativa Clinical Trials
4.4 Trial Type wise Hidradenitis Suppurativa Clinical Trials

5. Hidradenitis Suppurativa Average Enrollment Trends
5.1 Average Enrollment in Hidradenitis Suppurativa Trials by Year
5.2 Average Enrollment in Hidradenitis Suppurativa Trials by Phase
5.3 Average Enrollment in Hidradenitis Suppurativa Trials by Status
5.4 Average Enrollment in Hidradenitis Suppurativa Trials by Type of Trial

6. Companies Participating in Hidradenitis Suppurativa Clinical Trials
6.1 Hidradenitis Suppurativa Trials by Sponsor Type
6.2 Hidradenitis Suppurativa Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Hidradenitis Suppurativa Trials- Phase 1
7.2 Hidradenitis Suppurativa Trials- Phase 2
7.3 Hidradenitis Suppurativa Trials- Phase 3
7.4 Hidradenitis Suppurativa Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Hidradenitis Suppurativa Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Figure 5: Europe - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Figure 7: North America - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Figure 9: Hidradenitis Suppurativa Clinical Trials by Phase
Figure 10: Hidradenitis Suppurativa Clinical Trials by Trial Status
Figure 11: Hidradenitis Suppurativa Clinical Trials by Type
Figure 12: Hidradenitis Suppurativa Clinical Trials by Sponsor Type
Figure 13: Hidradenitis Suppurativa Clinical Trials by Leading Sponsors
Figure 14: Hidradenitis Suppurativa Average Enrollment by Phase
Figure 15: Hidradenitis Suppurativa Average Enrollment by Trial Status
Figure 16: Hidradenitis Suppurativa Average Enrollment by Type
Figure 17: Hidradenitis Suppurativa- Average Enrolment by Type of Sponsors
Figure 18: Hidradenitis Suppurativa- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Hidradenitis Suppurativa Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Table 5: Europe - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Table 7: North America - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Hidradenitis Suppurativa Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Hidradenitis Suppurativa Average Enrollment by Phase
Table 15: Hidradenitis Suppurativa Average Enrollment by Trial Status
Table 16: Hidradenitis Suppurativa Average Enrollment by Type
Table 17: Hidradenitis Suppurativa- Average Enrolment by Type of Sponsors
Table 18: Hidradenitis Suppurativa- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Bayer AG
  • Celgene Corp
  • Coherus BioSciences Inc
  • Innovation Pharmaceuticals Inc
  • Novartis AG
  • XBiotech Inc
Note: Product cover images may vary from those shown
Adroll
adroll